A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 75,216 shares of REGN stock, worth $53.7 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
75,216
Previous 73,808 1.91%
Holding current value
$53.7 Million
Previous $77.6 Million 1.93%
% of portfolio
0.37%
Previous 0.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$1024.09 - $1201.76 $1.44 Million - $1.69 Million
1,408 Added 1.91%
75,216 $79.1 Million
Q2 2024

Aug 13, 2024

SELL
$883.2 - $1071.19 $128,947 - $156,393
-146 Reduced 0.2%
73,808 $77.6 Million
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $1.78 Million - $1.96 Million
-1,973 Reduced 2.6%
73,954 $71.2 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $377,512 - $429,387
-487 Reduced 0.64%
75,927 $66.7 Million
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $16.3 Million - $19.9 Million
-23,521 Reduced 23.54%
76,414 $62.9 Million
Q2 2023

Aug 07, 2023

BUY
$700.03 - $830.35 $7.37 Million - $8.74 Million
10,522 Added 11.77%
99,935 $71.8 Million
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $7.42 Million - $9.01 Million
-10,901 Reduced 10.87%
89,413 $73.5 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $17.6 Million - $19.1 Million
-24,893 Reduced 19.88%
100,314 $72.4 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $7.55 Million - $9.53 Million
13,161 Added 11.75%
125,207 $86.3 Million
Q2 2022

Aug 10, 2022

SELL
$548.35 - $738.84 $22.6 Million - $30.5 Million
-41,230 Reduced 26.9%
112,046 $66.2 Million
Q1 2022

May 11, 2022

SELL
$595.12 - $698.43 $27.6 Million - $32.4 Million
-46,354 Reduced 23.22%
153,276 $107 Million
Q4 2021

Feb 10, 2022

BUY
$543.48 - $670.97 $49.4 Million - $61 Million
90,971 Added 83.72%
199,630 $128 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $30.3 Million - $36 Million
52,821 Added 94.6%
108,659 $65.8 Million
Q2 2021

Aug 10, 2021

SELL
$472.8 - $558.54 $13.2 Million - $15.6 Million
-27,991 Reduced 33.39%
55,838 $31.2 Million
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $14.3 Million - $17.6 Million
-32,058 Reduced 27.66%
83,829 $39.7 Million
Q4 2020

Feb 11, 2021

BUY
$478.3 - $607.98 $5.62 Million - $7.15 Million
11,759 Added 11.29%
115,887 $56 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $3.11 Million - $3.75 Million
5,703 Added 5.79%
104,128 $58.3 Million
Q2 2020

Aug 13, 2020

SELL
$493.32 - $643.92 $9.28 Million - $12.1 Million
-18,817 Reduced 16.05%
98,425 $61.4 Million
Q1 2020

May 13, 2020

SELL
$336.18 - $494.43 $9.85 Million - $14.5 Million
-29,290 Reduced 19.99%
117,242 $57.2 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $28.4 Million - $39 Million
103,589 Added 241.22%
146,532 $55 Million
Q3 2019

Nov 08, 2019

SELL
$273.46 - $318.39 $3.42 Million - $3.98 Million
-12,504 Reduced 22.55%
42,943 $11.9 Million
Q2 2019

Aug 09, 2019

SELL
$299.6 - $414.82 $23 Million - $31.8 Million
-76,750 Reduced 58.06%
55,447 $17.4 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $463,239 - $547,264
1,245 Added 0.95%
132,197 $54.3 Million
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $11.9 Million - $14.2 Million
35,323 Added 36.94%
130,952 $48.9 Million
Q3 2018

Nov 05, 2018

BUY
$351.14 - $408.51 $18.2 Million - $21.2 Million
51,903 Added 118.7%
95,629 $38.6 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $1.14 Million - $1.38 Million
4,003 Added 10.08%
43,726 $15.1 Million
Q1 2018

Apr 30, 2018

SELL
$315.82 - $393.78 $950,302 - $1.18 Million
-3,009 Reduced 7.04%
39,723 $13.7 Million
Q4 2017

Feb 12, 2018

SELL
$358.63 - $469.95 $701,838 - $919,692
-1,957 Reduced 4.38%
42,732 $16.1 Million
Q3 2017

Nov 13, 2017

SELL
$431.38 - $504.0 $905,898 - $1.06 Million
-2,100 Reduced 4.49%
44,689 $20 Million
Q2 2017

Aug 14, 2017

BUY
N/A
46,789
46,789 $0

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.